STACKSTONE WEALTH, LLC’s United Therapeutics UTHR Stock Holding History

STACKSTONE WEALTH, LLC’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.45M	Buy	+4,515	New	+$2.33M	0.24%	118

Other funds holding UTHR

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

VFP

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Davidson Capital Management Corpus Christi, Texas $604M AUM 18.09% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

STACKSTONE WEALTH, LLC's UTHR Position: Q3 2026 in Review

STACKSTONE WEALTH, LLC opened a new position in United Therapeutics (UTHR) in Q3 2026: 4,515 shares worth $2.45M. The stake represents 0.24% of the portfolio and ranks #118 among its holdings.

104 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

STACKSTONE WEALTH, LLC held 4,515 shares of United Therapeutics worth $2.45M as of Q3 2026.
United Therapeutics was a new STACKSTONE WEALTH, LLC position in Q3 2026.
United Therapeutics made up 0.24% of STACKSTONE WEALTH, LLC's portfolio in Q3 2026, its #118 holding.
104 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on STACKSTONE WEALTH, LLC's 13F filing for Q3 2026, filed 19 Oct 2026.